Research

AHCC (active hexose correlated compound)

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Indication: Post-operative liver cancer

Source: Journal of Hepatology, 2002;37:78-86.

Research: A total of 269 consecutive patients with histologically confirmed hepatocellular carcinoma (HCC) were studied. The study examined 10 different parameters related to liver function after surgery.

Results: Of the 269 patients, 113 received AHCC orally after undergoing curative surgery. Researchers at the University of Osaka, Japan, concluded that, compared with the control group, the AHCC group had a significantly longer period with no disease recurrence, a higher survival rate and an increased overall survival rate.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters